HIV and SARS-CoV-2 infection in postpartum Kenyan women and their infants.
HIV and SARS-CoV-2 infection in postpartum Kenyan women and their infants.
复制标题
DOI:
10.1371/journal.pone.0278675
复制
发表时间:
2023
期刊:
影响因子:
3.7
通讯作者:
Gantt, Soren
中科院分区:
文献类型:
--
作者:
Begnel, Emily R.;Chohan, Bhavna H.;Ojee, Ednah;Adhiambo, Judith;Owiti, Prestone;Ogweno, Vincent;Holland, LaRinda A.;Fish, Carolyn S.;Richardson, Barbra A.;Khan, Adam K.;Maqsood, Rabia;Lim, Efrem S.;Sadarangani, Manish;Lehman, Dara A.;Slyker, Jennifer;Kinuthia, John;Wamalwa, Dalton;Gantt, Soren
HIV may increase SARS-CoV-2 infection risk and COVID-19 severity generally, but data are limited about its impact on postpartum women and their infants. As such, we characterized SARS-CoV-2 infection among mother-infant pairs in Nairobi, Kenya. We conducted a nested study of 62 HIV-uninfected and 64 healthy women living with HIV, as well as their HIV-exposed uninfected (N = 61) and HIV-unexposed (N = 64) infants, participating in a prospective cohort. SARS-CoV-2 serology was performed on plasma collected between May 1, 2020-February 1, 2022 to determine the incidence, risk factors, and symptoms of infection. SARS-CoV-2 RNA PCR and sequencing was also performed on available stool samples from seropositive participants. SARS-CoV-2 seropositivity was found in 66% of the 126 mothers and in 44% of the 125 infants. There was no significant association between SARS-CoV-2 infection and maternal HIV (Hazard Ratio [HR] = 0.810, 95% CI: 0.517–1.27) or infant HIV exposure (HR = 1.47, 95% CI: 0.859–2.53). Maternal SARS-CoV-2 was associated with a two-fold increased risk of infant infection (HR = 2.31, 95% CI: 1.08–4.94). Few participants (13% mothers, 33% infants) had symptoms; no participant experienced severe COVID-19 or death. Seroreversion occurred in about half of mothers and infants. SARS-CoV-2 sequences obtained from stool were related to contemporaneously circulating variants. These data indicate that postpartum Kenyan women and their infants were at high risk for SARS-CoV-2 infection and that antibody responses waned over an average of 8–10 months. However, most cases were asymptomatic and healthy women living with HIV did not have a substantially increased risk of infection or severe COVID-19.
登录
查看更多内容
DOI:
10.1093/infdis/jiaa691
发表时间:
2021-02-13
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
Goldstein E;Lipsitch M;Cevik M
通讯作者:
Cevik M
DOI:
10.1016/s0140-6736(21)00441-4
发表时间:
2021-05-22
期刊:
Lancet (London, England)
影响因子:
--
作者:
African COVID-19 Critical Care Outcomes Study (ACCCOS) Investigators
通讯作者:
African COVID-19 Critical Care Outcomes Study (ACCCOS) Investigators
影响因子:
10.7
作者:
Hoang DT;Chernomor O;von Haeseler A;Minh BQ;Vinh LS
通讯作者:
Vinh LS
DOI:
10.3390/ijerph18073554
发表时间:
2021-03-30
影响因子:
--
作者:
Lee KW;Yap SF;Ngeow YF;Lye MS
通讯作者:
Lye MS
影响因子:
1.6
作者:
Dong Y;Li Z;Ding S;Liu S;Tang Z;Jia L;Liu J;Liu Y
通讯作者:
Liu Y